Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
7.33
-0.08 (-1.08%)
At close: Oct 2, 2026, 4:00 PM EDT
7.32
-0.01 (-0.14%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Eikon Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Eikon Therapeutics stock has a consensus rating of "Buy" and an average price target of $24.6. The average 1-year stock price forecast is 235.61% higher than the current stock price, while the lowest is $4.00 (-45.43%) and the highest is $32 (+336.56%).
Price Target: $24.6 (+235.61%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eikon Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 1 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $32 | Buy | Maintains | $32 | +336.56% | Sep 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $32 | Buy | Reiterates | $32 | +336.56% | Aug 17, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $29 | Buy | Maintains | $29 | +295.63% | Aug 17, 2026 |
| Wedbush | Wedbush | Sell Maintains $7 → $5 | Sell | Maintains | $7 → $5 | -31.79% | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.41
from -115.29
EPS Next Year
-6.33
from -6.41
EPS and Forward PE are based on non-GAAP adjusted numbers.